Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE

Prostate-Specific Membrane Antigen (PSMA) Guided Approach for bIoCHEmical Relapse After Prostatectomy- A Prospective Observational Study-PSICHE

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This observational study was designed to evaluate progression free survival after PSMA-PET/CT based salvage approach for patients affected by biochemical relapse after radical prostatectomy.

Who May Be Eligible (Plain English)

Who May Qualify: - Signed willing to sign a consent form - Age \>18 - Patient suitable for 68Ga-PSMA PET/CT re-staging according to clinical practice (Previous radical prostatectomy with histological result of Prostate adenocarcinoma +/- postoperative prostate bed radiotherapy (adjuvant or salvage setting), with a biochemical relapse defined as a PSA \> 0.2 and \<1 Who Should NOT Join This Trial: - ADT administration within 6 months from study enrollment - Persistent elevation of PSA after RP measured within 16 weeks from surgery (\> 0.1 ng/ml) Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Signed informed consent * Age \>18 * Patient suitable for 68Ga-PSMA PET/CT re-staging according to clinical practice (Previous radical prostatectomy with histological result of Prostate adenocarcinoma +/- postoperative prostate bed radiotherapy (adjuvant or salvage setting), with a biochemical relapse defined as a PSA \> 0.2 and \<1 Exclusion Criteria: * ADT administration within 6 months from study enrollment * Persistent elevation of PSA after RP measured within 16 weeks from surgery (\> 0.1 ng/ml)

Locations (1)

AOU Careggi Radiation Oncology Unit
Florence, Italy